Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings

被引:17
|
作者
Imai, Ryosuke [1 ]
Ono, Masafumi [2 ]
Nishimura, Naoki [1 ]
Suzuki, Koyu [3 ]
Komiyama, Nobuyuki [2 ]
Tamura, Tomohide [1 ]
机构
[1] St Lukes Int Hosp, Thorac Ctr, Dept Pulm Med, 9-1 Akashi Cho, Chuo City, Tokyo 1048560, Japan
[2] St Lukes Int Hosp, Cardio Vasc Ctr, Tokyo, Japan
[3] St Lukes Int Hosp, Dept Pathol, Tokyo, Japan
关键词
D O I
10.1016/j.jtho.2018.10.156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E36 / E38
页数:4
相关论文
共 50 条
  • [1] Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
    Liu, Zhijie
    Fan, Yiming
    Guo, Jun
    Bian, Ning
    Chen, Dongdong
    [J]. ESC HEART FAILURE, 2022, 9 (03): : 2020 - 2026
  • [2] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Feifei Wang
    Yang Liu
    Wei Xu
    Changjing Zhang
    Jianhong Lv
    Shaolin Ma
    [J]. Journal of Medical Case Reports, 15
  • [3] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Wang, Feifei
    Liu, Yang
    Xu, Wei
    Zhang, Changjing
    Lv, Jianhong
    Ma, Shaolin
    [J]. JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [4] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED FULMINANT MYOCARDITIS
    Yan, Crystal L.
    Rodriguez, Beatriz P. Rivera
    Lopez, Juan
    Martinez, Moises Vasquez
    Andrade-Bucknor, Sharon N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3457 - 3457
  • [5] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS: A CASE REPORT
    Saeed, Mariam
    Khan, Zinobia
    Bachan, Moses
    Raju, Bindu
    Khan, Muneer
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [6] Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis
    Menachery, Sherin M.
    Hang, Yiwei
    Pritchard, Laura
    Poklepovic, Andrew
    Bottinor, Wendy
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 199 : 33 - 36
  • [7] Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab
    Yamaguchi, Shogo
    Morimoto, Ryota
    Okumura, Takahiro
    Yamashita, Yuta
    Haga, Tomoaki
    Kuwayama, Tasuku
    Yokoi, Tsuyoshi
    Hiraiwa, Hiroaki
    Kondo, Toru
    Sugiura, Yuki
    Watanabe, Naoki
    Kano, Naoaki
    Kohno, Kei
    Fukaya, Kenji
    Sawamura, Akinori
    Yokota, Kenji
    Ishii, Hideki
    Nakaguro, Masato
    Akiyama, Masashi
    Murohara, Toyoaki
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (06) : 812.e1 - 812.e3
  • [8] Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
    Barham, Whitney
    Guo, Ruifeng
    Park, Sean S.
    Herrmann, Joerg
    Dong, Haidong
    Yan, Yiyi
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [9] An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report
    Hashimoto, Takahiko
    Takahashi, Kosuke
    Ito, Kosuke
    Iwade, Kahori
    Torii, Atsushi
    Sugihara, Minoru
    Kondo, Haruka
    Hara, Toru
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03) : 218 - 222
  • [10] IMMUNE CHECKPOINT INHIBITOR (ICI) MYOCARDITIS: A CASE REPORT ON SEVERE PEMBROLIZUMAB-RELATED MYOCARDITIS
    Nebrejas, Kevin Edward
    Tacdol, Dillon
    Alimurung, Kyle Martin
    [J]. CHEST, 2023, 164 (04) : 535A - 536A